News-Medical.Net on MSN
CRISPR-based Cellgorithm technology ushers in a new era of cell programming
Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of ...
Goldenberries taste like a cross between pineapple and mango, pack the nutritional punch of a superfood, and are increasingly ...
Casgevy, now a "national priority" drug, helped kids with sickle cell and thalassemia, results which may help toward a label ...
TipRanks on MSN
CRISPR Therapeutics AG: Stock surge amid challenges
Crispr Therapeutics AG ( ($CRSP) ) has risen by 9.03%. Read on to learn why. Crispr Therapeutics AG has seen its stock price rise by 9.03% over ...
Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of new research in Science Advances detailing the company’s CRISPR-based ...
The company will begin filing to global regulators in the first half of 2026. Read more at straitstimes.com. Read more at ...
MedPage Today on MSN
Gene Therapy Also Effective in Younger Children With Inherited Blood Disorders
Exa-cel could provide benefit before kids develop chronic organ damage ...
The Healthy @Reader's Digest on MSN
Breaking study: An experimental new drug could cut cholesterol for life
The exciting discovery offers a hopeful new idea: A one-time treatment may be able to, someday, replace cholesterol-lowering ...
Spaceflight, genetic tinkering, and the psychological implications of technological acceleration are explored with accuracy ...
Vertex Pharmaceuticals Incorporated today announced data from multiple studies demonstrating the clinical benefits of CASGEVY® (exagamglogene autotemcel) in people ages 5 years and older living with ...
Kickstart your UPSC Prelims prep early—begin with current affairs for a strong foundation. Brush up your current affairs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback